Six subjects with normal left ventricular function and seven subjects who were 1 to 3 years after cardiac transplantation were studied. Acetylcholine, atropine, and the 13-adrenergic agonist dobutamine were infused via the left main coronary artery, and changes in left ventricular contractile function were assessed by measurement of peak +dP/dt. Intracoronary dobutamine increased +dP/dt by 70+15% and 66±20% in the normal subjects and transplant T he autonomic nervous system plays an important role in the regulation of cardiac function.' Increased sympathetic activity causes increases in heart rate and atrioventricular conduction and, conversely, increased parasympathetic activity causes slowing of heart rate and atrioventricular conduction. Although increased sympathetic activity can exert a profound influence to increase left ventricular contractility, the role of cholinergic pathways in modulating ventricular contractile function in humans is not clear. However, changes in parasympathetic tone can substantially attenuate the positive inotropic response to a variety of sympathetic stimuli in anesthetized2-5 and conscious6,7 dogs, and vagal fibers can be seen to innervate the human left ventricle, albeit to a lesser density than the sinoatrial or atrioventricular nodes. 8 The purpose of this study was to determine whether cholinergic pathways in the human heart modulate basal left ventricular contractility or the positive inotropic response to 8-adrenergic stimulation. Acetylcholine, a cholinergic agonist; atropine, a cholinergic antagonist; and dobutamine, a 3-adrenergic agonist, were infused directly into the left main coronary artery of patients with angiographically normal coronary arteries, and left ventricular peak +dP/dt was measured to assess changes in contractility.9 We studied six subjects with normal left ventricular function and, to address a po-tential action of acetylcholine or atropine to affect cardiac function by modulating presynaptic norepinephrine release, seven subjects who had undergone cardiac transplantation from 1 to 3 years previously.
Methods

Study Population
The study population consisted of 13 adults (10 men and 3 women) who were referred for diagnostic catheterization. All subjects were in normal sinus rhythm. Six of the subjects (normal subjects) were referred for evaluation of a chest pain syndrome. In all of these subjects, the coronary arteries were found to be free of significant stenosis by angiography. Five of these subjects were free of symptoms of left ventricular dysfunction or congestive heart failure and had received medications only for treatment of chest pain (diltiazem, one subject; verapamil, one subject; and atenolol, one subject). One subject had chronic renal insufficiency and had received digoxin and captopril for pulmonary congestion but was found to have normal left and right ventricular size and function by echocardiography and had normal resting hemodynamics at the time of study. All medications were withheld on the night before study, except atenolol, which was withheld for 48 hours before study. Left ventricular ejection fraction determined by angiography (three subjects), echocardiography (two subjects), or radionuclide ventriculography (one subject) was normal in all six subjects. A second group of seven subjects (transplant recipients) were studied during their routine annual evaluation after cardiac transplantation. These subjects were studied from 1 to 3 years after transplantation (1 year, four subjects; 2 years, two subjects; and 3 years, one subject) and in all cases were free of clinical or histological evidence of cardiac rejection. The coronary arteries in these subjects were without significant stenosis by angiography. The medications in this group consisted of prednisone and cyclosporine A in all subjects. In addition, several subjects were receiving a convert- ing enzyme inhibitor (three subjects), a calcium channel antagonist (four subjects), or both (two subjects) for the control of high blood pressure. All medications were withheld on the night before study.
The study protocol was approved by the Committee for the Protection of Human Subjects From Research Risks at the Brigham and Women's Hospital, and written informed consent was obtained before study.
Hemodynamic Measurements
All subjects initially underwent routine diagnostic left and right heart catheterization via the femoral approach. Coronary angiography was performed with nonionic contrast media, and the research protocol was begun a minimum of 20 minutes after completion of the diagnostic catheterization. The methodology for intracoronary drug infusion and hemodynamic measurements was as reported previously.9-12 In brief, a 6F L-4 Judkins catheter (Cordis Laboratories, Miami, Fla) was advanced to the ostium of the left main coronary artery and positioned as for routine contrast injection. The (5) After the hemodynamic measurements had been made during acetylcholine infusion, acetylcholine was continued with the concurrent infusion of dobutamine at the rate used for the first dobutamine infusion. (6) Acetylcholine and dobutamine were discontinued for a minimum of 5 minutes and until +dP/dt had returned to baseline. (7) Atropine was infused at a rate of 12 gg/min. (8) After hemodynamic measurements had been made during atropine infusion, atropine was continued with the concurrent infusion of dobutamine at the rate used for the first dobutamine infusion. (9) After completion of the drug infusions, radiographic contrast was injected to confirm the continued position of the catheter in the left main coronary ostium.
Statistical Analysis
All data are presented as the mean+1 SEM. The significance of changes in each variable was tested by ANOVA for multiple observations.13 Intragroup and intergroup comparisons were made by paired or unpaired two-tailed Student's t tests, as appropriate. The statistical significance of differences in multiple observations was tested by means of the Bonferroni correction for repeated measures, such that a P value of <.05/n was required for statistical significance, where n is the number of comparisons tested.'2
Results
Baseline Hemodynamics
Baseline hemodynamics in the six normal subjects were within normal limits (Table 1 ). In the seven transplant recipients, baseline hemodynamics were within normal limits, with the exception of left and right heart filling pressures, which were mildly elevated. There were no significant differences between normal subjects and transplant recipients, with the exception of mean pulmonary artery wedge pressure, which was higher in the transplant recipients.
Effects of Intracoronary Dobutamine, Acetylcholine, and Atropine on Basal Contractility Heart rate, left ventricular end-diastolic pressure, and mean arterial pressure were unaffected by any of the intracoronary drug infusions in normal subjects or transplant recipients (Table 2) . Dobutamine infusion increased left ventricular +dP/dt by 70+15% and 66±20% in the normal subjects and transplant recipients, respectively (Fig 1) . Discontinuation of dobutamine resulted in a return of +dP/dt to control values bpm indicates beats per minute. There were no significant changes in heart rate, left ventricular end-diastolic pressure, or mean arterial pressure by ANOVA for multiple observations.13 (Fig 1) . Neither acetylcholine nor atropine had a significant effect on baseline +dP/dt in normal subjects or transplant recipients (Fig 1) .
Effect of Acetylcholine on the Response to Dobutamine
Concurrent infusion of acetylcholine with dobutamine caused a significantly smaller increase in +dP/dt than did dobutamine alone, in both normal subjects (66±10% reduction) and transplant recipients (79±9% reduction) (Fig 2) . Effect of Atropine on the Response to Dobutamine
In normal subjects, the concurrent infusion of atropine and dobutamine caused a significantly greater response (25±7% greater) than did dobutamine alone (Fig 3) . In transplant recipients, atropine had no effect on the response to dobutamine. augmented by atropine. In contrast, under basal conditions (eg, in the absence of exogenous 3-adrenergic receptor stimulation), neither acetylcholine nor atropine had a detectable effect on left ventricular contractility. Thus, the positive inotropic response to f-adrenergic receptor stimulation is significantly modulated by stimulation and inhibition of cholinergic receptors in the heart. Work by several investigators has demonstrated a significant sympathetic-parasympathetic interaction in the regulation of left ventricular function in dogs. Levy and colleagues1l2,4,5 showed that vagal nerve stimulation inhibited the positive inotropic response to sympathetic nerve stimulation, that the inhibitory effect of parasympathetic nerve stimulation was greater than would be predicted by pure additivity, and that the effect of vagal stimulation was increased as the level of sympathetic activity was raised, a phenomenon they called "accentuated antagonism." Hollenberg et a13 showed that intracoronary infusion of acetylcholine in anesthetized dogs had little effect on basal left ventricular +dP/dt but significantly attenuated the positive inotropic responses to both sympathetic nerve stimulation and exogenously administered norepinephrine. Vatner The effects of acetylcholine reported here are probably not due to a presynaptic site of action since acetylcholine was equally effective at decreasing the positive inotropic responses to dobutamine in transplanted and normal hearts. To the extent that the transplanted heart is denervated, this observation suggests that a presynaptic mechanism was not involved. Although there is evidence of partial sympathetic reinnervation in some patients after transplantation,20 analysis of the heart rate variability of donor hearts has not shown evidence of vagal reinnervation. 21 Furthermore, in our transplant recipients, atropine failed to potentiate the response to dobutamine, as it did in normal subjects. Because our experiments were conducted in subjects under resting conditions, we cannot exclude the possibility that a presynaptic interaction might occur in other situations associated with increased sympathetic nerve activity (eg, exercise or heart failure). Based on the effects of sympathetic and parasympathetic nerve stimulation in dogs,15'16 it is likely that if acetylcholine exerts a presynaptic effect in humans, it would be most evident with increased sympathetic nerve activity.
Discussion
Certain experimental limitations need to be considered. First, left ventricular peak +dP/dt, the measure of contractility used in these studies, can be influenced by changes in heart rate and loading conditions.22 This potential confounding factor appears to have had little effect since heart rate, systemic arterial pressure, and left ventricular end-diastolic pressure were unaffected by any of the intracoronary infusions under the conditions of these studies. A second limitation is that both the d-and l-stereoisomers of racemic (dl) dobutamine, the 18-adrenergic agonist used in these studies, can also interact with a-adrenergic receptors.23 Since a-adrenergic receptor stimulation exerts a positive inotropic effect in human hearts,12 this could potentially confound the interpretation of the pharmacology demonstrated here. However, this possibility is unlikely since we have found that the positive inotropic effect of intracoronary dldobutamine is not affected by the a-adrenergic antagonist phentolamine,24 likely reflecting the opposing actions of the d-and i-isomers of dobutamine on a-adrenergic receptors. 25 Finally, the endothelium-dependent vasodilatory effect of acetylcholine may have contributed to the decreased inotropic response to dobutamine by causing a reduction in the final intracoronary concentration of the drug. However, we think it is unlikely that this mechanism played a major role because (1) the magnitude of change in coronary blood flow with acetylcholine is not sufficient to account for the magnitude of decrease in dobutamine response that was observed, and (2) a comparable or greater effect of acetylcholine was seen in transplant recipients and patients with dilated cardiomyopathy (unpublished data) who have a reduced endothelium-dependent vasodilatory response to acetylcholine. 26, 27 In summary, we have shown that cholinergic receptors in the human heart can modulate the positive inotropic response of the left ventricle to p-adrenergic receptor stimulation. These observations have implications with regard to the assessment of left ventricular physiology and pharmacology and provide a mechanism by which exogenous cholinergic agonists or antagonists or alterations in endogenous parasympathetic tone might influence left ventricular function.
